Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001513160-12-000004
Filing Date
2012-02-17
Accepted
2012-02-17 16:40:31
Documents
6
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT annualreport123111.htm 10-K 1076580
2 CONSENT OF FRIEDMAN LLP ex23a.htm EX-23.A 3030
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex31a.htm EX-31.A 10181
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31b.htm EX-31.B 9890
5 SECTION 1350 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND CHIEF FINANCIAL OF ex32.htm EX-32.A 10009
11 PERFORMANCE GRAPH performancegraph1.jpg GRAPHIC 44762
  Complete submission text file 0001513160-12-000004.txt   1172623
Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 7324529556
PHARMOS CORP (Filer) CIK: 0000713275 (see all company filings)

EIN.: 363207413 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-11550 | Film No.: 12623171
SIC: 2834 Pharmaceutical Preparations